Linear IgA bullous dermatosis following human papillomavirus vaccination

European Journal of Dermatology

Volumn 22, Issue 6, 2012, Pages 787-788

  Ikeya, Shigeki ^a   Urano, Shoko ^a   Tokura, Yoshiki ^b  

^a JA Shizuoka Kohseiren Enshu Hospital   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOSPORIN; ERYTHROMYCIN; IMMUNOGLOBULIN A; PREDNISOLONE; WART VIRUS VACCINE;

ADULT; CASE REPORT; CELL INFILTRATION; CONJUNCTIVITIS; DETERIORATION; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG SAFETY; EOSINOPHILIA; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; INSECT BITE; LABORATORY TEST; LEUKOCYTE COUNT; LINEAR IGA BULLOUS DERMATOSIS; MICROSCOPY; NOTE; PAPULE; PATIENT ASSESSMENT;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; LINEAR IGA BULLOUS DERMATOSIS; PAPILLOMAVIRUS VACCINES; PREDNISOLONE;

EID: 84877019668     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1851     Document Type: Note

References (6)

1. Wojnarowska F, Venning VA, Burge SM. Immunobullous Disease. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. 7th edn. Oxford:Wiley-Blackwell Scientific Publications, 2004: 41-43.
2. Lauren A-W, Alyse MM, Meera M, et al. Linear IgA bullous dermatosis following influenza vaccination. Dermatology Online Journal 2009. Available at: dermatology-s10.cdlib.org/1511/ (accessed 02 Mar 2012).
3. Pinto LA, Edwards J, Castle PE, et al. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like-particles. J Infect Dis, 2003; 188: 327-38.
4. Denise N-H, Daniel W, John TS, et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95: 1128-37.
5. Lucía P-C, Ingrid A-L, Carmen G-G, et al. The quadrivalent human papillomavirus vaccine: Erythema multiforme and cutaneous side effects after administration. Dermatology 2010; 221: 197-200.
6. Wanda, R., William, LM., Kathrin, UJ., et al. Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant. J Immune Based Ther Vaccines 2005. Available at: www.jibtherapies.com/conent/3/1/2 (accessed 12 Mar 2012).